Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | S024362 | — |
No additional AE reported; a patient received an expired dose of VARIVAX; This spontaneous report was received from a consumer or other non-health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 10-SEP-2021, the received an expired dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (dose, route of administration, anatomical location were not reported, lot number S024362 which was verified to be valid, expiration date not reported but upon internal review established on 06-AUG-2021). the expired vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT). for prophylaxis. There was no adverse event reported. This is an invalid case due to the lack of patient identifiers.
Sterile diluent